state-licensed medical marijuana

Marijuana has been reclassified from Schedule I to Schedule III under a new order, aligning it with substances like ketamine and testosterone. This change affects state-licensed medical marijuana by categorizing it alongside certain prescription medications.

Acting Attorney General Todd Blanche signed an order under President Trump’s direction to reclassify state-licensed medical marijuana as a less-dangerous drug, marking a significant policy shift. The change does not federally legalize marijuana but alters its regulation in states that permit medical use.

The Trump administration reclassified state-licensed medical marijuana as a less dangerous substance under federal law. However, this action does not legalize marijuana use at the federal level, maintaining existing restrictions.

Acting Attorney General Todd Blanche signed an order reclassifying state-licensed medical marijuana as a less dangerous drug. The reclassification aims to adjust the legal status of medical marijuana under state regulations.

The Trump administration reclassified state-licensed medical marijuana as a less dangerous drug under an order signed by Acting Attorney General Todd Blanche. The move reduces regulatory oversight and offers tax breaks to licensed operators, though it does not fully legalize medical marijuana.